Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comparative Study
. 2017 Jun;15(6):841-849.e1.
doi: 10.1016/j.cgh.2016.11.032. Epub 2016 Dec 7.

Cost Utility Analysis of Topical Steroids Compared With Dietary Elimination for Treatment of Eosinophilic Esophagitis

Affiliations
Comparative Study

Cost Utility Analysis of Topical Steroids Compared With Dietary Elimination for Treatment of Eosinophilic Esophagitis

Cary C Cotton et al. Clin Gastroenterol Hepatol. 2017 Jun.

Abstract

Background & aims: Topical corticosteroids or dietary elimination are recommended as first-line therapies for eosinophilic esophagitis, but data to directly compare these therapies are scant. We performed a cost utility comparison of topical corticosteroids and the 6-food elimination diet (SFED) in treatment of eosinophilic esophagitis, from the payer perspective.

Methods: We used a modified Markov model based on current clinical guidelines, in which transition between states depended on histologic response simulated at the individual cohort-member level. Simulation parameters were defined by systematic review and meta-analysis to determine the base-case estimates and bounds of uncertainty for sensitivity analysis. Meta-regression models included adjustment for differences in study and cohort characteristics.

Results: In the base-case scenario, topical fluticasone was about as effective as SFED but more expensive at a 5-year time horizon ($9261.58 vs $5719.72 per person). SFED was more effective and less expensive than topical fluticasone and topical budesonide in the base-case scenario. Probabilistic sensitivity analysis revealed little uncertainty in relative treatment effectiveness. There was somewhat greater uncertainty in the relative cost of treatments; most simulations found SFED to be less expensive.

Conclusions: In a cost utility analysis comparing topical corticosteroids and SFED for first-line treatment of eosinophilic esophagitis, the therapies were similar in effectiveness. SFED was on average less expensive, and more cost effective in most simulations, than topical budesonide and topical fluticasone, from a payer perspective and not accounting for patient-level costs or quality of life.

Keywords: Cost Effectiveness; Cost Utility; Diet; Eosinophilic Esophagitis; Steroids; Treatment.

PubMed Disclaimer

Figures

Figure 1
Figure 1
A: Simplified Markov Structure. B: Dietary Elimination Process.
Figure 1
Figure 1
A: Simplified Markov Structure. B: Dietary Elimination Process.
Figure 2
Figure 2
Incremental Costs and Quality Adjusted Life Years per Cohort in 10,000 Probabilistic Sensitivity Analysis Iterations Comparing Initial Topical Fluticasone to Initial Six Food Elimination Diet.
Figure 3
Figure 3
Incremental Costs and Quality Adjusted Life Years per Cohort in 10,000 Probabilistic Sensitivity Analysis Iterations Comparing Initial Topical Budesonide to Initial Six Food Elimination Diet.
Figure 4
Figure 4
Cost Effectiveness Acceptability Curve of Two Topical Steroids Compared to Six Food Elimination Diet

References

    1. Dellon ES, Gonsalves N, Hirano I, et al. ACG clinical guideline: Evidenced based approach to the diagnosis and management of esophageal eosinophilia and eosinophilic esophagitis (EoE) Am J Gastroenterol. 2013;108:679–692. quiz 693. - PubMed
    1. Dellon ES, Liacouras CA. Advances in Clinical Management of Eosinophilic Esophagitis. Gastroenterology. 2014;147:1238–1254. - PMC - PubMed
    1. Aceves SS, Bastian JF, Newbury RO, et al. Oral viscous budesonide: a potential new therapy for eosinophilic esophagitis in children. Am J Gastroenterol. 2007;102:2271–2279. quiz 2280. - PubMed
    1. Dohil R, Newbury R, Fox L, et al. Oral viscous budesonide is effective in children with eosinophilic esophagitis in a randomized, placebo-controlled trial. Gastroenterology. 2010;139:418–429. - PubMed
    1. Gupta SK, Vitanza JM, Collins MH. Efficacy and safety of oral budesonide suspension in pediatric patients with eosinophilic esophagitis. Clin Gastroenterol Hepatol. 2015;13:66 e3–76 e3. - PubMed

Publication types